These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 17414560)

  • 1. Megadose methylprednisolone therapy: 2 decades of experience and empiric success in need of explanation, validation, and exploitation.
    Kamen BA
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):211-2. PubMed ID: 17414560
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of megadose methylprednisolone versus conventional dose prednisolone in hematologic disorders.
    Yetgin S; Ozsoylu S
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):253-9. PubMed ID: 17414568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral megadose methylprednisolone administration in hematologic disorders.
    Ozsoylu S
    Pediatr Hematol Oncol; 1994; 11(5):565, 563-4. PubMed ID: 7826852
    [No Abstract]   [Full Text] [Related]  

  • 4. About megadose methylprednisolone.
    Ozsoylu S; Yetgin S
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):864-5. PubMed ID: 18090943
    [No Abstract]   [Full Text] [Related]  

  • 5. Megadose methylprednisolone for Evans syndrome.
    Ozsoylu S
    Pediatr Hematol Oncol; 2000 Dec; 17(8):725-6. PubMed ID: 11127409
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparision of the apoptotic effects on lymphoblasts and on increase of myeloid lineage cells of a short-time, high-dose methylprednisolone and the conventional-dose prednisolone treatments in children with acute lymphoblastic leukemia.
    Erduran E; Tekelioglu Y; Karakas T; Gedik Y; Mert FM
    Pediatr Hematol Oncol; 2006; 23(7):587-98. PubMed ID: 16928654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of megadose methylprednisolone and high dose dexamethasone for traumatic optic neuropathy.
    Chuenkongkaew W; Chirapapaisan N
    J Med Assoc Thai; 2002 May; 85(5):597-603. PubMed ID: 12188391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corticosteroids for treatment of rheumatoid arthritis].
    Tanaka Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():468-71. PubMed ID: 15799401
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glucocorticoid-induced osteoporosis--epidemiology and pathogenesis].
    Suzuki Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():668-72. PubMed ID: 15035206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Corticosteroid therapy in collagen disease].
    Iida N; Murata D; Sugimoto M; Hirose S
    Nihon Rinsho; 1994 Mar; 52(3):740-6. PubMed ID: 8164376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution on the local application of corticosteroids].
    Schieferstein G
    Z Haut Geschlechtskr; 1966 Nov; 41(9):354-63. PubMed ID: 5995307
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glucocorticoids].
    Hayashi T
    Nihon Rinsho; 1992 Mar; 50(3):503-8. PubMed ID: 1588738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternate-day vs shorter-interval steroid administration.
    Walton J; Watson BS; Ney RL
    Arch Intern Med; 1970 Oct; 126(4):601-7. PubMed ID: 4918711
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous amyloidosis associated with amyopathic dermatomyositis.
    Taniguchi Y; Horino T; Terada Y
    J Rheumatol; 2009 May; 36(5):1088-9. PubMed ID: 19435977
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
    Levchenko NI; Piradov MA; Pirogov VN
    Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in treatment of infantile spasms with pulse methylprednisolone.
    Mytinger JR; Quigg M; Taft WC; Buck ML; Rust RS
    J Child Neurol; 2010 Aug; 25(8):948-53. PubMed ID: 20142465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection.
    Costa DC; de Castro RS; Kara-Jose N
    Eye (Lond); 2009 Mar; 23(3):708-14. PubMed ID: 18820657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megadose methylprednisolone therapy for Kasabach-Merritt syndrome.
    Ozsoylu S
    J Pediatr; 1996 Dec; 129(6):947-8. PubMed ID: 8969749
    [No Abstract]   [Full Text] [Related]  

  • 20. IgE-mediated hypersensitivity reactions to methylprednisolone.
    Aranda A; Mayorga C; Ariza A; Doña I; Blanca-Lopez N; Canto G; Blanca M; Torres MJ
    Allergy; 2010 Nov; 65(11):1376-80. PubMed ID: 20486918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.